DUAL INHIBITION OF THE TWO SOURCES OF CHOLESTEROL. THE MODERN METHODOLOGY OF REDUCING CARDIOVASCULAR RISC

Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 2

Abstract

This study evaluated the efficacy and safety of Ezetimibe co-administered with Simvastatine therapy in 104 hypercholesterolemic patients with coronary heart disease (CHD) or diabetes who had not achieved their low-density lipoprotein cholesterol (LDL-C) goal <100mg/dl while on a stable dose of Simvastatine 20mg/day. Significantly more patients achieved an LDL-C goal <100mg/dl with Ezetimibe than Placebo (51% vs. 35%). Compared to Placebo, co-administration of Ezetimibe with Simvastatine led to significantly greater reductions in LDL-C, total cholesterol, triglycerides, non-high-density lipoprotein cholesterol (non-HDL-C) and apolipoprotein B; HDL-C was as well increased. Co-administration of Ezetimibe and Simvastatine was well tolerated, with an overall safety profile similar to Simvastatine alone.

Authors and Affiliations

Gabriela Dale, M. I. Popescu, Loredana Popa, A. R. Popa, R. Fritsch

Keywords

Related Articles

DIABETES IN PREGNANCY: PREPREGNANCY CARE FOR TYPE 1 AND TYPE 2 DIABETES

Preconception counseling is the education of, and the discussion with, women of reproductive age about pregnancy and contraception. It is essential component of every consultation in primary and/or specialist care. Preco...

PANCREAS TRANSPLANTATION – BENEFITS AND RISKS FOR DIABETIC PATIENTS

Pancreas transplantation is considered a valuable therapeutic option in diabetic patients, either alone or combined with renal allografts in transplant candidates with imminent or established end-stage renal disease. Imp...

The Impact Of An Educational Program In The Management Of Patients With Chronic Hepatitis C

Introduction: This study was designed to measure the impact of lifestyle changes, involving a diet therapy and physical exercises in patients with chronic hepatitis C (CHC). Methods: The study was conducted during Januar...

Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia And Metabolic Syndrome

Introduction and Objective: The aim of this study was to evaluate the relationship between lower urinary tract symptoms (LUTS), benign prostatic hyperplasia, and metabolic syndrome. Methods: 381 patients, over 45 years,...

Download PDF file
  • EP ID EP155379
  • DOI -
  • Views 106
  • Downloads 0

How To Cite

Gabriela Dale, M. I. Popescu, Loredana Popa, A. R. Popa, R. Fritsch (2011). DUAL INHIBITION OF THE TWO SOURCES OF CHOLESTEROL. THE MODERN METHODOLOGY OF REDUCING CARDIOVASCULAR RISC. Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 18(2), 151-156. https://europub.co.uk/articles/-A-155379